Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neoplasma ; 66(6): 1019-1023, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31607136

RESUMO

Aim of the study is to define the diagnostic accuracy of selected urinary protein biomarkers in the non-invasive detection of primary and recurrent urothelial carcinoma of the urinary bladder. The urinary levels of calprotectin, CD147, APOA4 and protein deglycase DJ-1 were examined in 255 individuals, including 60 controls with non-malignant urological disease, 61 patients with a history of urinary bladder cancer with negative cytology and negative cystoscopy and 134 patients with urinary bladder cancer. Urinary concentrations of biomarkers were determined by Enzyme-Linked Immunosorbent Assay (ELISA). During the follow-up of patients with non-muscle invasive bladder cancer (NMIBC), a group of 44 patients with cancer recurrence was compared to the group of 61 patients with a history of NMIBC but with no evidence of disease. Urinary concentrations of the evaluated markers did not reveal any significant difference between these groups. During the primary diagnosis, a group of 90 patients with primary bladder cancer and 60 subjects with benign disease were compared. Urinary levels of CD147 were not significantly higher in patients with tumors. The greatest diagnostic accuracy was observed in APOA4 (sensitivity 55.6, specificity 83.3, AUC 0.75), and lesser in calprotectin (sensitivity 39.4, specificity 87.7, AUC 0.66) and in DJ-1 (sensitivity 61.1, specificity 66.7, AUC 0.64), respectively. Apolipoprotein A4 may be used potentially as a supplemental urinary marker in the diagnosis of primary bladder cancer.


Assuntos
Apolipoproteínas A/urina , Basigina/urina , Complexo Antígeno L1 Leucocitário/urina , Proteína Desglicase DJ-1/urina , Neoplasias da Bexiga Urinária/diagnóstico , Biomarcadores Tumorais/urina , Humanos , Recidiva Local de Neoplasia , Sensibilidade e Especificidade , Neoplasias da Bexiga Urinária/urina
2.
Neoplasma ; 65(6): 958-964, 2018 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-29940774

RESUMO

A total of 56 RCC patients with staging ≥ pT1b were enrolled in a prospective study to assess the prognostic importance of serum levels of osteopontin (OP), stanniocalcin-1 (SC), FGF-23, alpha Klotho and 25-OH-D at the time of diagnosis in renal cell carcinoma (RCC) patients. The relationship between the serum level of the analyzed parameters and recurrence-free survival (RFS), overall survival (OS) and cancer-specific survival (CSS) was examined, and our control group consisted of 20 patients without cancer. The levels of osteopontin, stanniocalcin-1, FGF-23 and alpha Klotho were determined by Enzyme-Linked Immunosorbent Assay (ELISA) and 25-OH-D by chemiluminiscence immunoanalysis (CLIA). The follow-up period median was 46 months. Renal cell carcinoma recurred in 9 patients and 20 patients died during follow-up; 12 of them from RCC. The level of osteopontin and stanniocalcin-1 varied between the control group and RCC patients (at p=0.02 and p=0.0003). Higher levels of stanniocalcin-1 were detected in the metastatic RCC group than in the localized RCC group (p=0.003). Only the stanniocalcin-1 level at the time of surgery was associated with RFS (p=0.0004). Both OS and CCS were associated with the osteopontin, stanniocalcin-1 and FGF preoperative level. Patients with stanniocalcin-1 level over 1,277 pg/ml and osteopontin level over 100 ng/ml had 17.8 times higher and 7.9 times higher risk of dying from RCC progression, respectively (p<0.001 and p=0.002). High levels of osteopontin, stanniocalcin-1 and FGF 23 at the time of surgery are important prognostic factors related to CSS and OS. Patients with high stanniocalcin-1 level were at risk of tumor recurrence.


Assuntos
Carcinoma de Células Renais/diagnóstico , Glicoproteínas/sangue , Neoplasias Renais/diagnóstico , Osteopontina/sangue , Carcinoma de Células Renais/sangue , Intervalo Livre de Doença , Fator de Crescimento de Fibroblastos 23 , Fatores de Crescimento de Fibroblastos/sangue , Humanos , Neoplasias Renais/sangue , Recidiva Local de Neoplasia , Prognóstico , Estudos Prospectivos , Taxa de Sobrevida
3.
Cas Lek Cesk ; 146(10): 781-7, 2007.
Artigo em Tcheco | MEDLINE | ID: mdl-18020012

RESUMO

BACKGROUND: Evaluation of long-term results of uretroplastic using buckle mucosa indicated in long and multiple strictures or after reconstruction of hypospadies is presented. METHODS AND RESULTS: 49 cases of uretroplastic with buccal mucosa graft were performed. 28 patients had complicated strictures after multiple endoscopic or reconstructive operations. Onlay uretroplastic was performed in 35 cases, including ventral graft placing in first 8 patients, afterwards dorsal grafts were performed in 27 patients. In 6 cases whole circumference of urethra was replaced in two steps. The length of buccal graft varied between 30 and 80 mm, aprox. 63 mm, duplex graft was used in 3 cases in max. length of 140 mm. In follow-up on an average 45 months (3-140 months) it has occurred 6 recurrences of stricture; the need of open reoperation was in 3 patients (12.3%), 2 relative restrictures were solved by optic urethrotomy (4%). The reoccurrences appeared after ventral onlay in 2 cases (25%), after the dorsal onlay also in two cases (7.4%), after two-steps uretroplastic there was 20% (2 cases) of the reoccurrence rate. Duplex graft uretrolastics were in all cases without complications. Fistula has not occurred. All stricture recurrences were detected in period of 15 months. CONCLUSIONS: Buccal mucosa graft uretroplastic is long-lasting effectiveness method with low complication rate, especially in dorsal graft placing. Complication rate does not cohere with the length of graft, uretroplastic extent, nor stricture localization.


Assuntos
Mucosa Bucal/transplante , Obstrução Ureteral/cirurgia , Adolescente , Adulto , Idoso , Criança , Humanos , Masculino , Pessoa de Meia-Idade
4.
Cas Lek Cesk ; 146(10): 806-8, 2007.
Artigo em Tcheco | MEDLINE | ID: mdl-18020016

RESUMO

Laparoscopy is the most modern operative technique, the main advantage of which is the least invasivity. In urology, the laparoscopy has won its yield only in nineties of 20th century, but it was in urology, where the robots were launched as first, and nowadays using them it is possible to perform ablative/reconstructive surgery in a tiny intracorporeal space. The price of laparoscopic operations is high and has been the only limit up to now, but technical approaches and indications have already been fixed.


Assuntos
Hospitais Universitários/história , Laparoscopia/história , Adulto , República Tcheca , História do Século XX , História do Século XXI , Humanos
5.
Curr Issues Mol Biol ; 2(4): 103-12, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11471754

RESUMO

In Brassica species, self-incompatibility has been mapped genetically to a single chromosomal location. In this region several closely linked genes have been identified. One of them, S-locus receptor kinase (SRK), determines S haplotype specificity of the stigma and it's the key protein for SI reaction. The role of the S locus glycoprotein (SLG) gene remains unclear. In the last decade approximately 15 additional genes linked to S-locus have been found. Recently, a gene has been identified (SCR) that encodes a small cysteine-rich protein which is a candidate for the pollen ligand. In addition to S locus linked genes there are unlinked SLRgenes (S-locus related genes). In this review, we discuss the role of these genes and the current view on the self-incompatibility mechanism in Brassica.


Assuntos
Brassica/genética , Sequência de Aminoácidos , Brassica/crescimento & desenvolvimento , Mapeamento Cromossômico , Genes de Plantas , Glicoproteínas/genética , Modelos Biológicos , Dados de Sequência Molecular , Proteínas de Plantas/genética , Pólen/crescimento & desenvolvimento , Proteínas Quinases/genética , Homologia de Sequência de Aminoácidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...